전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
pyriproxyfen
piriproksifēns
마지막 업데이트: 2014-11-21
사용 빈도: 14
품질:
pyriproxyfen (mg)
piriproksifēns (mg)
마지막 업데이트: 2017-04-26
사용 빈도: 2
품질:
that list includes pyriproxyfen.
piriproksifēns ir minētajā sarakstā.
마지막 업데이트: 2014-11-08
사용 빈도: 1
품질:
dinotefuran / pyriproxyfen / permethrin
dinotefurāns / piriproksifēns / permetrīns
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
pyriproxyfen (iso) of a purity by weight of 97 % or more
piriproksifens (iso) ar tīrības pakāpi 97 masas % vai augstāku
마지막 업데이트: 2014-11-21
사용 빈도: 1
품질:
each 0.9 ml spot-on applicator contains dinotefuran 423 mg and pyriproxyfen 42.3 mg.
viens 0.9 ml aplikators pilināšanai uz ādas satur 423 mg dinotefurānu un 42.3 mg piriproksifēnu
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
it is therefore appropriate to include pyriproxyfen for use in product type 18 in annex i to that directive.
tāpēc ir lietderīgi piriproksifēnu iekļaut minētās direktīvas i pielikumā izmantošanai 18. veida produktos.
마지막 업데이트: 2014-11-08
사용 빈도: 1
품질:
each 0.9 ml spot-on applicator delivers: 423 mg dinotefuran and 42.3 mg pyriproxyfen.
viens 0.9 ml aplikators pilināšanai uz ādas satur 423 mg dinotefurānu un 42.3 mg piriproksifēnu.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
vectra 3d is a veterinary medicine that contains three active substances: dinotefuran, pyriproxyfen and permethrin.
vectra 3d ir veterinārās zāles, kas satur trīs aktīvās vielas: dinotefurānu, piriproksifēnu un permetrīnu.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
people with known hypersensitivity to dinotefuran, pyriproxyfen or dimethyl sulfoxide should avoid contact with this veterinary medicinal product.
personām ar pastiprinātu jutību pret dinotefurānu, piriproksifēnu vai dimetilsulfoksīdu vajadzētu izvairīties no saskares ar šīm veterinārajām zālēm.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
following topical application, dinotefuran and pyriproxyfen are partially absorbed through the dog’s skin leading to systemic exposure.
dinotefurāns un piriproksifēns daļēji uzsūcas caur suņa ādu, izraisot sistēmisku darbību.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
pharmacotherapeutic group: antiparasitic products, insecticides and repellents, other ectoparasiticides for topical use, pyriproxyfen, combinations.
farmakoterapeitiskā grupa: antiparazicīdi, insekticīdi un repelenti, citi ektoparazicīdi vietējai lietošanai, piriproksifēns, kombinācijas.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
amending directive 98/8/ec of the european parliament and of the council to include pyriproxyfen as an active substance in annex i thereto
ar ko groza eiropas parlamenta un padomes direktīvu 98/8/ek, lai iekļautu tās i pielikumā aktīvo vielu piriproksifēnu
마지막 업데이트: 2014-11-08
사용 빈도: 1
품질:
laboratory studies with each of the components, dinotefuran or pyriproxyfen, in rats and rabbits have not produced any evidence of maternotoxic, teratogenic or foetotoxic effects.
laboratoriskajos pētījumos par katru sastāvdaļu tika konstatēts, ka dinotefurāns vai piriproksifēns žurkām un trušiem neizraisa maternotoksisku, teratogēnu vai fetotoksisku iedarbību.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
after oral administration, pyriproxyfen is rapidly metabolized, principally by hydroxylation, and eliminated mainly in the faeces, and to a lesser extent in the urine.
pēc perorālas uzņemšanas piriproksifēns ātri metabolizējas hidroksilējoties un tiek izvadīts galvenokārt ar fēcēm, mazāk ar urīnu.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
pyriproxyfen (iso) of a purity by weight of 97 % or more (cas rn 95737-68-1)
piriproksifens (iso) ar tīrības pakāpi 97 masas % vai augstāku (cas rn 95737-68-1)
마지막 업데이트: 2014-11-21
사용 빈도: 3
품질:
for the implementation of the uniform principles of annex vi, the conclusions of the review report on pyriproxyfen, and in particular appendices i and ii thereof, as finalised in the standing committee on the food chain and animal health on 11 may 2010 shall be taken into account.
lai īstenotu vi pielikuma vienotos principus, ņem vērā pārtikas aprites un dzīvnieku veselības pastāvīgās komitejas 2010. gada 11. maijā pabeigtā pārskata ziņojuma secinājumus par piriproksifēnu un jo īpaši tā i un ii papildinājumu.
마지막 업데이트: 2014-11-21
사용 빈도: 1
품질:
amending annex i to council directive 91/414/eec as regards the specific provisions relating to the active substances clofentezine, diflubenzuron, lenacil, oxadiazon, picloram and pyriproxyfen
ar ko groza padomes direktīvas 91/414/eek i pielikumu attiecībā uz īpašajiem noteikumiem par aktīvajām vielām: klofentezīnu, diflubenzuronu, lenacilu, oksadiazonu, piklorāmu un piriproksifēnu
마지막 업데이트: 2014-11-21
사용 빈도: 1
품질:
amending council directive 91/414/eec to include clofentezine, dicamba, difenoconazole, diflubenzuron, imazaquin, lenacil, oxadiazon, picloram and pyriproxyfen as active substances
ar ko groza padomes direktīvu 91/414/eek, lai tajā kā darbīgo vielu iekļautu klofentezīnu, dikambu, difenokonazolu, diflubenzuronu, imazakvīnu, lenacilu, oksadiazonu, piklorāmu un piriproksifēnu
마지막 업데이트: 2014-11-17
사용 빈도: 1
품질: